Printer Friendly

BARR LABORATORIES ANNOUNCES ADDITIONAL ASSESSMENT

 BARR LABORATORIES ANNOUNCES ADDITIONAL ASSESSMENT
 POMONA, N.Y., Dec. 13 /PRNewswire/ -- Barr Laboratories, Inc.


(AMEX: BRL) today released the following statement:
 Upon receipt and review of the actual judgment recently issued in connection with the breach of contract lawsuit which was the subject of the company's Nov. 20, 1991 press release, Barr Laboratories, Inc. learned that an additional $600,000 in pre-judgment interest had been assessed. An additional charge against earnings will have to be taken during the quarter ending Dec. 31, 1991 in order to reserve for this interest charge.
 The method and underlying rationale for charging this interest, as well as the entire judgment, are being appealed by the company.
 Barr Laboratories is a prime manufacturer of a broad range of multi- source pharmaceutical products with manufacturing facilities located in both Northvale, N.J. and Pomona.
 -0- 12/13/91
 /CONTACT: Louis J. Guerci, vice president-finance of Barr Laboratories, 914-362-1100/
 (BRL) CO: Barr Laboratories, Inc. ST: New York IN: MTC SU:


SH-OS -- NY047 -- 2447 12/13/91 14:54 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 13, 1991
Words:172
Previous Article:TENNANT DECLARES REGULAR CASH DIVIDEND OF 30 CENTS, ACHIEVES 20TH CONSECUTIVE YEAR OF INCREASE
Next Article:WASHINGTON STATE DSHS: NEW STATE AUTHORITY LEADS TO SUCCESSFUL CORRECTION OF VIOLATIONS AT SHERWOOD TERRACE NURSING CENTER
Topics:


Related Articles
BARR LABORATORIES RELEASES FIRST QUARTER FINANCIAL RESULTS
BARR ANNOUNCES SECOND QUARTER SALES AND EARNINGS
BARR RELEASES SALES AND EARNINGS FOR FISCAL YEAR ENDED JUNE 30, 1992
BARR LABORATORIES RELEASES FIRST QUARTER FINANCIAL RESULTS
BARR LABORATORIES' FIRST QUARTER NET SALES CLIMB 23%; NET EARNINGS UP 19%
Barr Laboratories' Reports $0.12 Earnings Per Share For First Quarter 1997; Sales Climb 19% to $64 million
Barr Laboratories Reports $0.15 EPS for Second Quarter 1997; Sales of $67 Million Represent 17% Increase
Barr Laboratories Announces $1.00 EPS for Third Quarter 1997; Board Authorizes 3-for-2 Stock Split in Recognition of Milestone Achievements
Barr Laboratories' First Quarter 1999 EPS Increases to $0.48; Products Launched in Past 12 Months Drive Earnings Increase.
Barr Reports First Quarter 2000 EPS of $0.49 Per Share; Quarter Includes Revenue Gain, Higher Margins, $9 Million Investment in R&D.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters